Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)

NCT00140985 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Disorder

Interventions

DRUG: MK0954, losartan potassium/Duration of Treatment: 20 weeks
DRUG: Comparator: amlodipine / Duration of Treatment: 20 weeks

Sponsor

Organon and Co